References
- . Alestig, K., Dornbusch, K., Ericson, C., Kallings, L.-O., Kamme, C., Nordbring, F., Norrby, R. & Wallmark, G.: Resistensbestämning av bakterier: Ny indelning i känslighetsgrupper – S, I och R. Läkartidningen 75: 4346, 1978.
- . Andersson, K.-E.: On the pharmacokinetics of cephalosporin antibiotics. Scand J Infect Dis, Suppl. 13: 37, 1978.
- . Baird-Parker, A. C.: The classification of staphylococci and micrococci from world-wide sources. J Gen Microbiol 38: 363, 1965.
- . Dornbusch, K.: Assay of gentamicin concentrations in serum specimens by microbiological and radioenzymatic methods. Scand J Infect Dis 9: 227, 1977.
- . Ericsson, H. M. & Sherris, J. C.: Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand [B], Suppl. 217, 1971.
- . Eykyn, S., Jenkins, U., King, A. & Phillips, J.: Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin and cefamandole. Antimicrob Agents Chemother 9: 690, 1976.
- . Facklam, R. R., Padula, J. F., Thacker, L. G., Northam, E. C. & Sconyers, B. J.: Presumptive identification of groups A, B and D streptococci. Appl Microbiol 27: 107, 1974.
- . Foord, R. D.: Cefuroxime: Human pharmacokinetics. Antimicrob Agents Chemother 9: 741, 1976.
- . Geddes, A. M., McGhie, D., Ball, A. P. & Gould, I.: Studies with cefuroxime and cefoxitin. Scand J Infect Dis, Suppl. 13: 78, 1978.
- . Goto, S.: The in vitro and in vivo antibacterial activity of cefuroxime. Proc R Soc Med 70, Suppl. 9: 56, 1977.
- . Hänninen, P., Saarimaa, H., Toivanen, P. & Kasanen, A.: Clinical profile of cefuroxime in sixty-four patients. Proc R Soc Med 70, Suppl. 9: 111, 1977.
- . Holdeman, L. V. & Moore, W. E. C.: Anaerobe laboratory manual. Virginia Polytechnic Institute and State University, Blacksburg, Virginia, 1972.
- . Jailing, B., Malmborg, A.-S., Lindman, A. & Boreus, L.-O.: Evaluation of a micromethod for determination of antibiotic concentrations in plasma. Eur J Clin Pharmacol 4: 150, 1972.
- . Kattan, S., Cavanogh, P. & Williams, J. D.: Relationship between β-lactamase production by H. influenzae and sensitivities to penicillin and cephalosporins. J Antimicrob Chemother 1: 79, 1975.
- . Laverdiere, M., Wheeler, N. & Sabath, L. D.: Cefuroxime resistance to staphylococcal β-lactamases. Proc R Soc Med 70, Suppl. 9: 72, 1977.
- . Lindberg, A. A., Nord, C.-E., Hellgren, M. & Sjöberg, L.: Identification of gram-negative aerobic fermentors in a clinical bacteriological laboratory. Med Microbiol Immunol (Berl) 159: 201, 1974.
- . Morton, H. E. & Cohn, J.: Coagulase and deoxyribonuclease activities of staphylococci isolated from clinical sources. Appl Microbiol 23: 725, 1972.
- . O'Callaghan, C. & Harding, S. M.: The pharmacokinetics of cefuroxime in man in relation to its antibacterial activity. Proc R Soc Med 70, Suppl. 9: 4, 1977.
- . Sabath, L. D., Garner, C., Wilcox, C. & Finland, M.: Effect of inoculum and of β-lactamase on anti-staphylococcal activity of thirteen penicillins and cephalosporins. Antimicrob Agents Chemother 8: 344, 1975.
- . Shah, P. M., Helm, E. R. & Stille, W.: Cefuroxime: Clinical evaluation. Proc R Soc Med 70, Suppl. 9: 103, 1977.
- . Svensson, R.: Clinical evaluation of cefuroxime. Proc R Soc Med 70, Suppl. 9: 98, 1977.
- . Sykes, R. B. & Matthew, M.: The β-lactamases of gram-negative bacteria and their role in resistance to β-lactam antibiotics. J Antimicrob Chemother 2: 115, 1976.